Wpływ różnych klas leków hipotensyjnych na ryzyko rozwoju cukrzycy typu 2 – nowa metaanaliza

Milad Nazarzadeh i wsp. Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis. Lancet 2021;98:1803-1810

Investigation of the effects of five major classes of antihypertensive drugs showed that in comparison to placebo, angiotensin-converting enzyme inhibitors (RR 0·84 [95% 0·76–0·93]) and angiotensin II receptor blockers (RR 0·84 [0·76–0·92]) reduced the risk of new-onset type 2 diabetes; however, the use of β blockers (RR 1·48 [1·27–1·72]) and thiazide diuretics (RR 1·20 [1·07–1·35]) increased this risk, and no material effect was found for calcium channel blockers (RR 1·02 [0·92–1·13]).

Lancet, 13 listopada 2021

0 replies on “Wpływ różnych klas leków hipotensyjnych na ryzyko rozwoju cukrzycy typu 2 – nowa metaanaliza”